This
stock has been moving in a range for the
last three months. The range seems to be more dominated by more selling than
buying. It seems to signal distribution rather than accumulation. Volume is not
coming in like the other Pharma stocks. Also the stock has not shown any
tendency for breakout like it’s peers.
No comments:
Post a Comment